Artha Sootra - Company Dashboard

Governance Classic Home

Eris Lifesciences LtdPharmaceuticalsINE406M01024Consolidated₹1234.10+4.20 (+0.34%)

Valuation

Market Cap₹16.81K Cr

TTM PE23.98x

Forward PE20.97x

PEG2.54

Book Value₹304.25

P/B4.06x

TTM EPS₹51.46

Fwd EPS₹58.85

TTM Revenue₹3.33K Cr

TTM PAT₹718.39 Cr

TTM EBITDA₹1.16K Cr

TTM EBIT₹875.35 Cr

Last Qtr PAT₹187.14 Cr

Last Qtr EBITDA₹309.35 Cr

Last Qtr EBIT₹235.93 Cr

Profitability

ROE17.33%

ROCE12.63%

TTM NPM21.58%

TTM EBITDA %34.86%

Curr OPM20.90%

Last OPM16.37%

Curr NPM—

Last NPM—

Curr EPS₹13.26

Last EPS₹10.28

Balance sheet

Equity₹13.87 Cr

Reserve₹4.13K Cr

Total Debt₹2,429.50 Cr

D/E0.59x

Interest %24.80%

Curr Interest₹46.42 Cr

Price / range

Close₹1234.10

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.34%

1W+6.72%

1M+4.17%

3M-10.76%

6M-10.04%

1Y-22.11%

2Y-5.04%

3Y+42.93%

5Y+51.37%

Diwali-17.69%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1860.00	₹4.46L Cr	40.70	12.31%
DIVISLAB	10320.50	₹2.74L Cr	93.64	17.45%
TORNTPHARM	4750.00	₹1.61L Cr	80.24	11.42%
LAURUSLABS	2340.00	₹1.26L Cr	94.28	21.98%
ZYDUSLIFE	1197.90	₹1.21L Cr	28.77	15.39%
DRREDDY	1373.00	₹1.15L Cr	40.86	7.11%
CIPLA	1411.00	₹1.14L Cr	39.34	8.06%
MANKIND	2540.00	₹1.05L Cr	46.75	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	482.24-25.9%	443.99	277.31	315.29	650.50	1,821.74
Other Income	19.24	26.38	26.97	25.07	23.59	98.31
Total Income	501.48-25.6%	470.37	304.28	340.36	674.09	1,920.05
Interest	42.06	42.16	42.70	45.20	46.50	179.54
Expenditure	-382.07+13.1%	-406.23	-337.05	-321.80	-439.42	-1,543.33
PBDT	0	0	0	0	0	0
EBITDA	183.11-38.3%	119.90	21.78	77.35	296.88	612.33
Depreciation	-40.88	-39.98	-38.82	-38.66	-39.30	-154.38
EBIT	142.23-44.8%	79.92	-17.04	38.69	257.58	457.95
PBT	83.51-64.4%	64.14	-32.77	3.89	234.67	362.05
Tax	45.64	-15.84	24.17	-0.80	-85.10	-118
Equity	13.87	13.86	13.85	13.62	0	13.85
OPM	16.65	13.64	-10.77	1.14	36.08	18.86
Net Profit	129.15-13.7%	48.30	-8.60	3.09	149.57	244.05
NPM	25.75	10.27	-2.83	0.91	22.99	12.71
EPS	9.32-15.1%	3.49	-0.63	0.23	10.98	17.86

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,821.74+7.3%	1,697.75+14.2%	1,486.71+11.7%	1,330.73+9.5%	1,215.73+9.6%	1,108.83
Other Income	98.31	35.51	34.83	17.26	28.99	10
Total Income	1,920.05+10.8%	1,733.26+13.9%	1,521.53+12.9%	1,347.99+8.3%	1,244.72+11.3%	1,118.83
Expenditure	-1,543.33+4.3%	-1,613.21-35.3%	-1,192.70-30.9%	-911.08-15.9%	-786.18-7.7%	-729.94
Interest	-179.54	-220.24	-57.42	-20.81	-2.99	-0.78
PBDT	0	0	0	0	0	0
EBITDA	612.33+25.9%	486.55+7.2%	453.82-10.2%	505.12+4.4%	484+16.0%	417.31
Depreciation	-154.38	-181.77	-102.39	-64.66	-51.46	-37.64
EBIT	457.95+50.3%	304.78-13.3%	351.43-20.2%	440.46+1.8%	432.54+13.9%	379.67
PBT	362.05+201.6%	120.05-63.5%	328.83-24.7%	436.91-4.7%	458.54+17.9%	388.89
Tax	-118	-42.66	-29.12	-38.90	-41.35	-38.29
Equity	13.85	13.62	0	0	0	0
OPM (%)	18.86	6.93	22.00	32.00	37.00	35.00
Net Profit	244.05+215.4%	77.39-74.2%	299.71-24.7%	398.01-4.6%	417.19+19.0%	350.61
NPM (%)	12.71	4.46	20.00	30.00	34.00	31.00
EPS (Rs)	17.86+213.9%	5.69-74.2%	22.04-24.7%	29.27-4.7%	30.70+18.9%	25.82
CEPS	17.83	5.68	22.01	29.23	30.70	25.80

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	892.37+12.6%	873.25	756.56	807.45	792.41	3,129.42
Other Income	3.20	2.39	2.23	0.02	2.81	7.75
Total Income	895.57+12.6%	875.64	758.79	807.47	795.22	3,137.17
Interest	46.42	46.65	45.62	48.82	49.55	192.67
Expenditure	-702.86-12.8%	-695.75	-598.18	-645	-622.83	-2,481.48
PBDT	0	0	0	0	0	0
EBITDA	309.35+7.3%	296.22	273.57	281.61	288.21	1,120.11
Depreciation	-73.42	-72.07	-69.57	-70.34	-69.08	-279.50
EBIT	235.93+7.7%	224.15	204	211.27	219.13	840.61
PBT	156.81-9.0%	179.89	160.61	145.23	172.39	638.45
Tax	31.23	-36.17	119.69	-36.52	-38.20	8.97
Equity	13.87	13.86	13.85	0	0	13.85
OPM	17.51	20.54	21.17	17.99	21.68	20.35
Net Profit	187.14+39.2%	143.32	279.10	108.83	134.47	647.51
NPM	20.90	16.37	36.78	13.48	16.91	20.64
EPS	13.26+50.3%	10.28	20.60	7.32	8.82	45.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	3,129.42+8.1%	2,893.64+44.0%	2,009.14+19.2%	1,685.15+25.1%	1,347.04+11.2%	1,211.86
Other Income	7.75	18.36	23.82	11.15	26.09	8.71
Total Income	3,137.17+7.7%	2,912+43.2%	2,032.96+19.8%	1,696.30+23.5%	1,373.14+12.5%	1,220.57
Expenditure	-2,481.48-2.4%	-2,423.19-51.3%	-1,601.72-24.0%	-1,291.66-38.7%	-930.94-12.7%	-826.07
Interest	-192.67	-231.29	-84.80	-26.17	-4.15	-1.80
PBDT	0	0	0	0	0	0
EBITDA	1,120.11+10.1%	1,017.20+50.7%	674.83+25.7%	536.75+10.7%	484.96+12.6%	430.58
Depreciation	-279.50	-315.46	-182.61	-117.09	-64.71	-42.99
EBIT	840.61+19.8%	701.74+42.6%	492.22+17.3%	419.66-0.1%	420.25+8.4%	387.59
PBT	638.45+30.6%	488.81+13.3%	431.24+6.6%	404.64-8.5%	442.20+12.1%	394.50
Tax	8.97	-114.20	-34.19	-30.48	-36.41	-39.36
Equity	13.85	13.62	0	0	0	0
OPM (%)	20.35	16.79	21.21	23.85	32.20	32.32
Net Profit	647.51+72.8%	374.67-5.6%	397.05+6.1%	374.16-7.8%	405.79+14.3%	355.14
NPM (%)	20.64	12.87	19.53	22.06	29.55	29.10
EPS (Rs)	45.33+75.4%	25.85-10.3%	28.82+2.6%	28.10-6.0%	29.89+14.3%	26.16
CEPS	45.26	25.81	28.79	28.07	29.88	26.14

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2027	Interim Dividend	7.21	29 May 2026
2025	Interim Dividend	7.35	13 Feb 2025
2023	Interim Dividend	7.35	11 Aug 2022
2022	Interim Dividend	6.01	05 Aug 2021
2021	Interim Dividend	5.5	13 Aug 2020
2020	Interim Dividend	2.87	19 Mar 2020

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split